Antibody drug conjugates: hitting the mark in pancreatic cancer?
Abstract Pancreatic cancer is one of the most common causes of cancer-related death, and the 5-year survival rate has only improved marginally over the last decade. Late detection of the disease means that in most cases the disease has advanced locally and/or metastasized, and curative surgery is no...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2023-10-01
|
| Colecção: | Journal of Experimental & Clinical Cancer Research |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13046-023-02868-x |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|